GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Fuss Brands Corp (OTCPK:FBDS) » Definitions » Risk Assessment

Fuss Brands (Fuss Brands) Risk Assessment


View and export this data going back to 2013. Start your Free Trial

What is Fuss Brands Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Fuss Brands is: No Data: Cannot be evaluated.


Competitive Comparison of Fuss Brands's Risk Assessment

For the Shell Companies subindustry, Fuss Brands's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuss Brands's Risk Assessment Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Fuss Brands's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Fuss Brands's Risk Assessment falls into.



Fuss Brands  (OTCPK:FBDS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


Fuss Brands Risk Assessment Related Terms

Thank you for viewing the detailed overview of Fuss Brands's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuss Brands (Fuss Brands) Business Description

Traded in Other Exchanges
N/A
Address
80 Broad Street, New York, NY, USA, 10004
Fuss Brands Corp is a shell company.
Executives
Lei Zhao director LEVEL 11, CHANGLIANG INTERNATIONAL BLDG, NO. 28, CHANGLIANG RD, NANGANG DISTRICT, HEILONGJIAN PROVINCE F4 150090
Zibing Pan director 1813 NW 176TH PL., EDMOND OK 73012
David Dong officer: Chief Financial Officer C/O FEIHE INTERNATIONAL, INC., 2275 HUNTINGTON DRIVE #278, SAN MARINO CA 91108
Xiaoying Lu officer: Interim CFO C/O RENHUANG PHARMACEUTICALS, INC., NO. 281, TAIPING ROAD, TAIPING DISTRICT, HARBIN,HEILONGJIANG PROVINCE F4 150050
Dianjun Pi director 281 TAIPING ROAD, DAOWAI DISTRICT, HARBIN, HEILONGJIANG F4 150300
Changxiong Sun director C/O RENHUANG PHARMACEUTICALS, INC., NO. 281, TAIPING ROAD, TAIPING DISTRICT, HARBIN, HEILONGJIANG PROVINCE F4 150050
Bingchun Wu director C/O RENHUANG PHARMACEUTICALS, INC., NO. 281, TAIPING ROAD, TAIPING DISTRICT, HARBIN, HEILONGJIANG PROVINCE F4 150050
Sean Shao director 21ST FLOOR, EVERBRIGHT BANK BUILDING, ZHUZILIN, FUTIAN DISTRICT, SHENZHEN, GUANGDONG F4 518040
Yan Yi Chen officer: Chief Financial Officer NO. 281, TAIPING ROAD, TAIPING DISTRICT, HARBIN, HEILONGJIANG PROVINCE F4 150050
Magnus Moliteus director 958 SUNSET RIDGE, BRIDGEWATER NJ 08807
Yanfei Kong director, officer: CFO 65 BROADWAY, SUITE 888, NEW YORK NY 10006
Li Shaoming director, 10 percent owner, officer: Chairman and CEO 281 TAIPING ROAD, DAOWAI DISTRICT, HARBIN, HEILONGJIAN F4 150300
Fanrong Meng director 201-5-602 YUNHUA SQUARE, KANGAN ROAD, HARBIN, HEILONGJIAN F4 150010
Kenneth Arevalo director 3200 BRISTOL STREET, SUITE 700, COSTA MESA CA 92626
Sutter Holding Co Inc 10 percent owner 100 SOUTH KING STREET, SEATTLE WA 98104

Fuss Brands (Fuss Brands) Headlines

No Headlines